Adline Chem Lab logo

Adline Chem Lab financials and balance sheet

BSE: 524604Pharmaceuticals & BiotechnologySmall Cap

Last close ₹15.79₹0.00 (0.00%)

Share price at the BSE close on 12 Oct 2026. Previous close ₹15.79.

52-week range of traded prices to 12 Oct 2026
₹7.60Low, 3 Dec 2025₹16.21High, 13 Oct 2025
Market cap
₹9.24 Cr4,835th largest listed
P/E
Lossover the last 12 months
P/B
Net worth zero or below
Dividend yield
Nonein the last 12 months
ROE
Net worth zero or below
ROCE
−685.2%
Debt to equity
Net worth zero or below
Volume, BSE
2,500

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Adline Chem Lab annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
  • Loss
Peak revenue ₹17 Cr, year to Mar 2017A loss in 6 of the 10 years shown

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue0.0
  2. Employee costs0.0
  3. Other expenses−0.1
  4. Operating profit−0.2
  5. Depreciation0.0
  6. Other income0.0
  7. One-off items0.0
  8. Finance costs−0.2
  9. Profit before tax−0.3
  10. Tax0.0
  11. Net profit−0.3

What the company owns

  • Cash and bank₹0 Cr
  • Plant, investments and other assets₹0 Cr

What pays for it: net worth and liabilities

  • Borrowings₹2 Cr

Profit and loss

Standalone, ₹ crore, years to March.Adline Chem Lab quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 15 JunMar 2020Filed 6 AugMar 2021Filed 6 JulMar 2022Filed 8 JunMar 2023Filed 30 MayMar 2024Filed 27 JunMar 2025Filed 10 JunMar 2026Filed 29 May
Revenue from operations17.28.25.66.66.30.70.00.00.00.0
16.07.35.09.96.61.00.80.20.30.2
Materials and goods bought12.84.61.44.93.00.50.30.00.00.0
Employee costs1.31.41.51.91.70.20.10.00.20.0
Other expenses1.91.32.13.11.80.40.50.10.10.1
Operating profit before depreciation1.20.90.6−3.3−0.2−0.3−0.8−0.2−0.3−0.2
Operating margin7.1%10.6%10.5%−50.6%−3.6%−40.2%––––
Materials, % of revenue74.2%56.4%25.5%74.0%47.9%65.2%––––
Employee costs, % of revenue7.7%17.0%27.1%29.5%27.1%25.1%––––
Other expenses, % of revenue11.0%16.0%36.9%47.1%28.6%50.0%––––
Depreciation and amortisation1.00.70.70.41.00.40.10.00.00.0
Operating profit after depreciation0.30.1−0.1−3.8−1.3−0.6−0.9−0.2−0.3−0.2
Other income0.10.20.20.00.00.21.00.00.20.0
Finance costs0.30.30.10.00.00.00.00.00.10.2
Profit before one-off items and tax0.00.00.0−3.8−1.3−0.40.1−0.1−0.2−0.3
One-off items––0.00.20.01.1−4.30.00.00.0
Profit before tax0.00.00.0−3.6−1.30.7−4.2−0.1−0.2−0.3
0.00.00.00.00.00.00.00.0−0.10.0
Net profit0.00.00.0−3.6−1.30.7−4.2−0.1−0.1−0.3
Other comprehensive income––0.00.00.00.00.00.00.00.0
Total comprehensive income––0.0−3.6−1.30.7−4.2−0.1−0.1−0.3
Net margin0.1%0.0%0.5%−54.1%−20.3%97.5%––––

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 15 JunMar 2020Filed 6 AugMar 2021Filed 6 JulMar 2022Filed 8 JunMar 2023Filed 30 MayMar 2024Filed 27 JunMar 2025Filed 10 JunMar 2026Filed 29 May
7.03.51.92.6−1.6−1.7−1.5−1.8
Share capital5.95.95.95.95.95.95.95.9
Reserves1.2−2.4−3.9−3.2−7.4−7.6−7.3−7.6
5.42.92.51.31.31.51.51.8
14.53.83.31.91.31.50.00.0
0.30.40.40.30.30.31.51.8
Total assets21.87.65.64.90.10.00.10.1
12.04.83.74.40.00.00.00.0
9.82.82.00.40.10.00.10.1
Net debt5.22.82.71.31.21.41.41.7
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 6 JulMar 2022Filed 8 JunMar 2023Filed 30 MayMar 2024Filed 27 JunMar 2025Filed 10 JunMar 2026Filed 29 May
0.060.210.01−0.02−0.23−0.16
0.060.210.01−0.02−0.33−0.16
0.290.28−0.180.13−0.270.02
Receivables−0.151.510.070.000.000.00
Inventories0.700.130.260.000.000.00
Payables−0.320.21−0.600.130.000.00
Other working capital0.06−1.580.080.00−0.270.02
Tax paid0.000.000.000.000.100.00
Capital spending0.010.000.000.000.000.00
Free cash flow0.050.210.01−0.02−0.23−0.16
0.120.000.000.000.000.00
−0.39−0.010.000.000.250.16
Dividends paid0.000.000.000.000.000.00
Shares bought back0.000.000.000.000.000.00
Shares issued0.000.000.000.000.000.00
Net change in cash−0.210.200.01−0.020.020.00
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Filed 15 JunMar 2020Filed 6 AugMar 2021Filed 6 JulMar 2022Filed 8 JunMar 2023Filed 30 MayMar 2024Filed 27 JunMar 2025Filed 10 JunMar 2026Filed 29 May
Earnings per share₹0.01–₹0.05−₹6.10−₹2.19₹1.23−₹7.24−₹0.25−₹0.02−₹0.48
Diluted earnings per share₹0.01–₹0.05−₹6.10−₹2.19₹1.23−₹7.24−₹0.25−₹0.02−₹0.48
Book value per share––₹12.02₹5.93₹3.30₹4.53−₹2.68−₹2.93−₹2.55−₹3.03
Shareholder yield––––0.0%0.0%0.0%–0.0%0.0%
Market cap at the year end (₹ crore)9.653.984.103.172.983.843.16–7.767.31

Ratios

Standalone, years to March.Adline Chem Lab PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Filed 15 JunMar 2020Filed 6 AugMar 2021Filed 6 JulMar 2022Filed 8 JunMar 2023Filed 30 MayMar 2024Filed 27 JunMar 2025Filed 10 JunMar 2026Filed 29 May
Revenue growth–−52.5%−31.5%17.8%−4.0%−88.4%−100.0%–––
Operating profit growth–−29.1%−31.9%–––––––
Net profit growth–−77.8%1,280.0%–––––––
––0.4%−67.9%−47.6%31.4%––––
–––−68.3 pts20.4 pts78.9 pts––––
From the net margin–––−43.4 pts42.5 pts276.1 pts––––
From asset turnover–––−32.2 pts−29.0 pts−195.1 pts––––
From borrowing–––7.4 pts6.9 pts−2.1 pts––––
Return on capital employed––−1.2%−59.5%−28.3%−16.3%–––−536.4%
Cash conversion–––––29.4%––––
Interest cover0.80.4––––––––
Debt to equity––0.760.821.300.50––––
Receivable days––136799135––––
Inventory days––83082471970–––
Payable days––434422834064–––
Cash conversion cycle, days––531119110−108––––
Working capital days––3210077−111––––
Asset turnover––0.260.450.960.140.000.000.000.00
Assets per rupee of net worth––3.112.802.452.294.56−0.03−0.04−0.04
Sales per rupee of plant––0.4956.38––––––
Capital spending to depreciation––––0.010.000.00–––
Interest cover is left blank for the years to Mar 2019, Mar 2020, Mar 2021, Mar 2022, Mar 2025 and Mar 2026: operating profit after depreciation is a loss, and a loss covers no interest bill. Debt to equity is left blank for the years to Mar 2023, Mar 2024, Mar 2025 and Mar 2026: net worth is below zero, so there is no shareholders' money to set the borrowings against. Return on capital employed is left blank for the years to Mar 2023, Mar 2024 and Mar 2025: net worth and borrowings together come to nought or less, so there is no money employed to set the operating profit against. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
−388.8%
Measure5 years3 years
Asset turnover, average0.030.00

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−0.18−0.40−0.16
Cash from investing0.000.000.00
Cash from financing0.400.410.16
Capital spending0.000.000.00
Dividends paid0.000.000.00
Shares bought back0.000.000.00
Shares issued for cash0.000.000.00
Borrowings raised0.660.660.28
Borrowings repaid0.000.000.00

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––54––––
Altman Z-scorePublished threshold 1.81–––––0.39−418.43–––
Beneish M-scorePublished threshold −1.78––––−3.77−2.86––––
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––−22.099.64−172.24−244.66159.56−169.85
Receivables growth less revenue growthOur threshold 0 percentage points–––−49.0914.61−7.140.00–––
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––−308.52−26.2750.21−53.97–––
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––−63.180.01−13.63––––
Assets under construction, years of additionsOur threshold 2 years of additions––––0.000.000.00–––
Effective tax ratePublished threshold 17.16 per cent35.7192.869.21––0.00––––
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––0.00––––
A threshold marked as ours has no published figure; it is the line we read the check against.